The same drugs can be employed for managing obesity, both in patients with diabetes and without it, because various studies have revealed that, also in patients without diabetic disease, GLP1-R agonists are effective in promoting weight loss in relation to a placebo [30]. This evidence concerns the gene GLP1R and diabetes mellitus.